6 Analysts Assess Precigen: What You Need To Know
Portfolio Pulse from Benzinga Insights
Precigen (NASDAQ:PGEN) has been analyzed by 6 analysts, showing a range of bullish to somewhat bullish sentiments. The average 12-month price target has increased by 29.07% to $8.17. Despite positive analyst ratings, Precigen faces financial challenges with declining revenue, negative net margin, and low ROE and ROA.
June 03, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Precigen has received predominantly bullish ratings from analysts, with an average 12-month price target increase of 29.07% to $8.17. However, the company faces significant financial challenges, including a 42.46% decline in revenue, negative net margin, and low ROE and ROA.
The bullish analyst ratings and increased price target suggest positive short-term sentiment. However, the company's financial challenges, such as declining revenue and negative margins, may temper this optimism.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100